Medical Information Technology Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Medical Information Technology Inc (MITII) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Medical Information Technology Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 512M vs 346M combined for tracked competitors (59.7% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-10.3% annualized vs trailing 12 months), vs decelerating (-21.0%) for its tracked peer group.
- Growth: Medical Information Technology Inc generated -5.4% revenue growth year over year in Q3 2020, vs -0.5% for its tracked competitors combined.
- Profitability: Its 26.7% net margin compares with 7.7% for the peer group.
- Peer revenue share: Medical Information Technology Inc accounted for 62.7% of combined revenue among its tracked peer group, down from 63.8% a year earlier.
- Peer differentiation: Revenue per employee of $0.14M compares with $0.10M for the peer group (1.4x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
MITII Sales vs. its Competitors, Q3 2020
Medical Information Technology Inc reported revenue contraction of 5.35 % year on year in Q3 2020, below its competitors' combined revenue change of -0.53 %.
With a net margin of 26.69 %, Medical Information Technology Inc achieved higher profitability than its competitors (7.71 %).
Medical Information Technology Inc generated 62.67 % of the combined sales of its peer group, down from 63.82 % a year earlier.
Medical Information Technology Inc vs. its Competitors, Q3 2020
Revenue growth, year on year
Net income growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Medical Information Technology Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Medical Information Technology Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (3) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (8) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Medical Information Technology Inc's competitor groups requires a Commercial License.
For context: the Software & Programming industry grew revenue 16.0% year over year, combined, vs -5.4% for Medical Information Technology Inc. Medical Information Technology Inc's share of combined industry revenue moved from 0.04% to 0.04%, a loss of 0.01 percentage points.
Medical Information Technology Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Medical Information Technology Inc | Yes | Yes | No | No |
| Competitors combined (1) | ||||
| High-Confidence Competitors (3) | ||||
| Similar Growth & Profitability (8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 0.00 % (0 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
MITII Stock Performance relative to its Competitors
MITII Stock Performance relative to High-Confidence Competitors
MITII Stock Performance relative to Similar Growth & Profitability Competitors
Publicly Traded Peers of Medical Information Technology Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Medical Information Technology Inc | - | 511.50 |
| Trubridge Inc | 382.19 | 345.90 |
| SUBTOTAL | 382.19 | 857.40 |
Sources: Medical Information Technology Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Medical Information Technology Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Medical Information Technology Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Cerner Corporation | Named by the company | 85% |
| Trubridge Inc | Named by the company | 85% |
| Veradigm Inc | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Medical Information Technology Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Medical Information Technology Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Trubridge Inc | Financial Health 61.75 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Medical Information Technology Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Medical Information Technology Inc | - | 138,244 | 20,181 |
| Trubridge Inc | 382 | 98,828 | 1,257 |
| PEERS TOTAL | 382 | 98,828 | 1,257 |
Medical Information Technology Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Software & Programming industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (343 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 100.00 % | 64.28 % (avg) | +35.7 pp |
| Operating Margin | 17.68 % | industry median | +23.2 pp |
| EBITDA Margin | 18.40 % | 2.53 % (avg) | +15.9 pp |
| Capital Intensity (Capex / Revenue) | 0.72 % | 4.79 % (avg) | -4.1 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Medical Information Technology Inc's Strategic Group Map
Every company in Medical Information Technology Inc's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Medical Information Technology Inc is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Medical Information Technology Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.72 % vs industry average 4.79 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Medical Information Technology Inc's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Medical Information Technology Inc's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Medical Information Technology Inc's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Medical Information Technology Inc falls in the Low attractiveness / High strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Medical Information Technology Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 23.2 points above the industry median.
Weaknesses
- Return on equity 12.0 points below the industry aggregate.
- Latest-quarter revenue run-rate is decelerating (-10.3% annualized vs trailing 12 months).
Opportunities
- Industry revenue growing at a healthy 11.6% median pace.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-21.0% annualized).
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Medical Information Technology Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Medical Information Technology Inc | 0.43 | 6.27 | - |
| Trubridge Inc | 0.41 | 1.82 | 0.93 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Medical Information Technology Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Medical Information Technology Inc | Q3 2020 | -5.3 % | -66.3 % |
| Trubridge Inc | Q1 2026 | -1.1 % | +10.2 % |
| PEERS TOTAL | -3.6 % | -65.9 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Medical Information Technology Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Medical Information Technology Inc | Q3 2020 | - | -38.7 % |
| Trubridge Inc | Q1 2026 | -3.9 % | -14.1 % |
Medical Information Technology Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Medical Information Technology Inc | 11.67% | 13.18% | 14.01% |
| Trubridge Inc | 1.10% | 1.28% | 2.48% |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Medical Information Technology Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Medical Information Technology Inc | - | - |
| Trubridge Inc | 94.02 | 1.10 |
| PEERS AVERAGE | 4.83 | 0.45 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.